Precision Medicine News and Updates | Precision Medicine Online
WEBResearchers explored HER2 testing discordance, biomarkers of response, patient-reported outcomes, and the risk of lung-related disease. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Medicine Diagnostics
WEBBioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs. Sep 13, 2024. AbbVie's Telisotuzumab Vedotin Effective in NSCLC Patients With High, Intermediate c-MET Expression. Sep 12, 2024. Cancer Centers Look to New NGS-Based 'Frankenpanel' to Get Fast Info on Clinically Actionable Genes.
Precision Oncology News - Precision Medicine Online
WEBSep 16, 2024 · Indiana University, Indiana Biosciences Research Institute Form Precision Medicine Center. Sep 19, 2024. New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays. Sep 18, 2024. Amgen's Lumakras Combo Scores High Response Rate in First-Line KRAS-Mutant Colorectal Cancer. Sep 18, 2024.
AstraZeneca Nabs FDA Approval for Tagrisso in Stage III, …
WEB4 hours ago · NEW YORK – The US Food and Drug Administration on Wednesday approved AstraZeneca's Tagrisso (osimertinib) for certain patients with stage III EGFR-mutated non-small cell lung cancer. The EGFR inhibitor is indicated for patients with tumors harboring exon 19 deletions or exon 21 (L858R) mutations ...
Breaking News - Precision Medicine Online
WEB1 day ago · NIH Awards $27M for Genomics-Enabled Learning Health System Network. The agency has committed $5.4 million for the first year of the five-year program to establish a network to analyze and improve how genomic information is integrated into patient care. Sep 23, 2024.
Precision Medicine in 2023: Gene Therapies Take Center Stage …
WEBNEW YORK – 2023 was undoubtedly the year of the gene therapy in precision medicine. The US Food and Drug Administration last year approved several gene therapies that for the first time promise to treat, and even cure, rare, inherited diseases of …
Genetic Counselors Can Help Patients Sort Concerns, Set …
WEB2 days ago · NEW ORLEANS – Genetic counselors should help patients set realistic expectations when sorting through the risks and benefits of gene therapy, according to panelists at the National Society of Genetic Counselors annual meeting Saturday. As such, patients must grapple with whether this is a ...
FDA Expert Panel to Consider Limiting Gastric, Esophageal Cancer ...
WEB1 day ago · NEW YORK – The US Food and Drug Administration will ask experts in its Oncologic Drugs Advisory Committee (ODAC) on Thursday whether it should narrow two currently approved indications of checkpoint inhibitors — Merck's Keytruda (pembrolizumab) and Bristol Myers Squibb's Opdivo (nivolumab) — to patients with PD-L1-expressing gastric and gastroesophageal cancer.
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Genomics Research & Discovery | Precision Medicine Online
WEBMay 30, 2024 · BePRECISE Consortium Publishes Checklist for Reporting Precision Medicine Research Findings
Skip to content